Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from FOXO Technologies ( (FOXO) ).
On January 18, 2026, FOXO Technologies increased its authorized common stock from 2.5 billion to 10 billion shares, a move that gives the company significantly more flexibility to raise capital, pursue corporate transactions, or support future growth initiatives. Two days later, on January 20, 2026, the company announced that its flagship rural facility, Big South Fork Medical Center in East Tennessee, had expanded its clinical capabilities by adding inpatient tele-specialty services in cardiology, pulmonology, and nephrology through a partnership with Rural Physicians Group, and by implementing on-site echocardiography with professional interpretation via CompuMed. The hospital’s enhanced diagnostic and specialty-care offering is expected to reduce patient transfers, strengthen its role as a local care hub, and support FOXO’s strategy of building a technology-enabled rural care model that could improve access, sustain operations, and potentially increase net revenues for the subsidiary and its parent.
The most recent analyst rating on (FOXO) stock is a Hold with a $0.01 price target. To see the full list of analyst forecasts on FOXO Technologies stock, see the FOXO Stock Forecast page.
Spark’s Take on FOXO Stock
According to Spark, TipRanks’ AI Analyst, FOXO is a Neutral.
The score is weighed down primarily by persistent losses and cash burn despite improving revenue and gross margin trends, which heighten dilution/financing risk. Balance-sheet leverage has improved, but valuation support is limited by a negative P/E and no dividend. Corporate actions add strategic upside, but expanded share authorization and preferred changes increase dilution risk.
To see Spark’s full report on FOXO stock, click here.
More about FOXO Technologies
FOXO Technologies Inc., traded over-the-counter under the ticker FOXO, operates a diversified portfolio of four subsidiaries spanning rural healthcare, behavioral health, biospecimen sourcing, and biotechnology. Its Rennova Community Health unit owns and operates Big South Fork Medical Center, a critical access-designated acute care hospital in East Tennessee, while Myrtle Recovery Centers provides inpatient and outpatient behavioral health and addiction treatment services in the same region. Vector BioSource supplies information, data, and biospecimens to biotechnology, clinical research, and pharmaceutical companies, and FOXO Labs focuses on biotechnology solutions aimed at improving human health and lifespan across multiple industries.
Technical Sentiment Signal: Sell
Current Market Cap: $68.88K
See more data about FOXO stock on TipRanks’ Stock Analysis page.